CCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner
Chemokine receptor CCR5
Tumor progression
DOI:
10.1084/jem.20030580
Publication Date:
2003-11-03T22:23:02Z
AUTHORS (12)
ABSTRACT
Chemokines are implicated in tumor pathogenesis, although it is unclear whether they affect human cancer progression positively or negatively. We found that activation of the chemokine receptor CCR5 regulates p53 transcriptional activity breast cells through pertussis toxin-, JAK2-, and p38 mitogen-activated protein kinase-dependent mechanisms. blockade significantly enhanced proliferation xenografts from bearing wild-type p53, but did not a mutation. In parallel, data obtained primary clinical series showed disease-free survival was shorter individuals CCR5Delta32 allele than patients, only for those whose tumors expressed p53. These findings suggest influences p53-dependent manner.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (107)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....